Atreca - 53 Year Dividend History | BCEL
Historical dividend payout and yield for Atreca (BCEL) since 1971. The current TTM dividend payout for Atreca (BCEL) as of March 18, 2024 is $0.00. The current dividend yield for Atreca as of March 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.003B |
$0.000B |
|
Atreca is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. While more traditional oncology drug discovery approaches attempt to generate antibodies against known targets, Atreca?s approach relies on the human immune system to direct it to unique antibody-target pairs from patients experiencing a clinically meaningful, active immune response against their tumors. These unique antibody-target pairs represent a potentially novel and previously unexplored landscape of immuno-oncology targets.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
